NEWS RELEASES

November 23, 2019

Takeda Presents 18-Month Data from Pivotal Phase 3 Trial of Dengue Vaccine Candidate at the American Society of Tropical Medicine and Hygiene (ASTMH) 68th Annual Meeting

Learn more
November 06, 2019

Takeda’s Dengue Vaccine Candidate Demonstrates Protection in Children Ages Four to 16 Years, Regardless of Previous Dengue Exposure

Learn more
November 05, 2019

Takeda Unveils New Dengue Vaccine Manufacturing Plant in Germany

Learn more
LOAD MORE
Home

VIDEOS

VIDEOS

This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies. If you want more information about cookies, the types we use, and how to control them, please see Takeda's Cookie Policy page.

Close OK

YOU ARE ABOUT TO LEAVE THIS WEBSITE AND ENTER A WEBSITE OPERATED BY AN INDEPENDENT THIRD PARTY

The links to third-party websites contained on this website are provided solely for your convenience. Takeda does not control the content contained on any third-party website linked from this website. Your activities on those websites will be governed by the policies and practices of those third parties.

Please select "Continue" if you wish to be taken to this third-party website.